Empire Financial Management Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$218K Sell
182
-12,187
-99% -$12.5M 0.09% 134
2026
Q1
$11.4M Buy
12,369
+2,919
+31% +$2.96M 2.57% 5
2025
Q4
$10.2M Buy
9,450
+62
+0.7% +$59.3K 2.21% 7
2025
Q3
$7.16M Hold
9,388
1.64% 10
2025
Q2
$7.32M Hold
9,388
2.11% 7
2025
Q1
$7.75M Sell
9,388
-17
-0.2% -$14.1K 2.4% 5
2024
Q4
$7.26M Sell
9,405
-103
-1% -$85.3K 2.27% 5
2024
Q3
$8.42M Hold
9,508
2.59% 4
2024
Q2
$8.61M Sell
9,508
-12
-0.1% -$9.6K 2.85% 4
2024
Q1
$7.41M Sell
9,520
-6
-0.1% -$4.27K 2.45% 5
2023
Q4
$5.55M Sell
9,526
-5
-0.1% -$2.92K 2.17% 5
2023
Q3
$5.12M Sell
9,531
-1,434
-13% -$739K 2.23% 7
2023
Q2
$5.14M Sell
10,965
-353
-3% -$148K 2.05% 6
2023
Q1
$3.89M Buy
+11,318
New +$3.82M 1.58% 10

Other funds holding LLY

Empire Financial Management Company's LLY Position: Q2 2026 in Review

Empire Financial Management Company reduced its Eli Lilly (LLY) stake by 99% in Q2 2026, selling an estimated $12.5M and leaving 182 shares worth $218K. The position accounts for 0.09% of the portfolio, ranked #134.

Empire Financial Management Company first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. The position peaked at $11.4M in Q1 2026. 4,598 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Empire Financial Management Company held 182 shares of Eli Lilly worth $218K as of Q2 2026.
  • Empire Financial Management Company sold 12,187 Eli Lilly shares in Q2 2026, an estimated $12.5M.
  • Eli Lilly made up 0.09% of Empire Financial Management Company's portfolio in Q2 2026, its #134 holding.
  • Empire Financial Management Company first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • Empire Financial Management Company's Eli Lilly position peaked at $11.4M in Q1 2026.
  • 4,598 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Empire Financial Management Company's 13F filing for Q2 2026, filed 14 Aug 2026.